- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hyphens Pharma International Ltd (HYPH)
Hyphens Pharma International Ltd stock price live, this page displays SGX HYPH stock exchange data. View the HYPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hyphens Pharma International Ltd real time stock price chart below.
What Is the Hyphens Pharma International Ltd Stock Price Today?
The Hyphens Pharma International Ltd stock price today is 0.320.
What Is the Stock Symbol for Hyphens Pharma International Ltd?
The stock symbol for Hyphens Pharma International Ltd is "HYPH."
What Stock Exchange Does Hyphens Pharma International Ltd Trade On?
Hyphens Pharma International Ltd is listed and trades on the Singapore stock exchange.
Is Hyphens Pharma International Ltd a Good Stock to Buy?
Determining whether Hyphens Pharma International Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HYPH quote. (ISIN: SG1EE4000006)
What Is the Hyphens Pharma International Ltd Stock Price Today?
The Hyphens Pharma International Ltd stock price today is 0.320.
What Is the Stock Symbol for Hyphens Pharma International Ltd?
The stock symbol for Hyphens Pharma International Ltd is "HYPH."
What Stock Exchange Does Hyphens Pharma International Ltd Trade On?
Hyphens Pharma International Ltd is listed and trades on the Singapore stock exchange.
Is Hyphens Pharma International Ltd a Good Stock to Buy?
Determining whether Hyphens Pharma International Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HYPH quote. (ISIN: SG1EE4000006)
Singapore
Currency in SGD
0.320
-0.005(-1.54%)
Delayed Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.320
0.325
52 wk Range
0.260
0.395
High dividend Yield
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.3200.325
52 wk Range
0.2600.395
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.62%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.62%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
HYPH Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
0.415
Upside
+29.69%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Hyphens Pharma International Ltd Company Profile
Hyphens Pharma International Limited, together with its subsidiaries, operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally. It operates through Pharmaceutical and Medical Aesthetics; Proprietary Brands; and Digital Platform and E-Pharmacy segments. The Pharmaceutical and Medical Aesthetics segment markets and sells a range of pharmaceutical and medical aesthetics products, including the Stérimar nasal sprays, Bausch+Lomb eye drops, Vivomixx, Fenosup Lidose, and Piascledine products in ASEAN countries. This segment focuses on various therapeutic areas, such as dermatology, pediatrics and neonatology, allergy, otorhinolaryngology, orthopedics and rheumatology, radiology, cardiology and interventional cardiology, ophthalmology, gastroenterology, psychiatry, family medicine, and medical aesthetics. Its Proprietary Brands segment develops, markets, and sells dermatological products comprising Ceradan, TDF, and CG210; health supplements under the Ocean Health brand covering areas, such as heart, joint, physical, cognitive, eye, and health; and pharmaceuticals. The Digital Platform and E-Pharmacy segment operates a digital platform that services procurement needs of healthcare professionals, healthcare institutions, and retail pharmacies primarily in Singapore. The company was formerly known as Hyphens Pharma International Pte Ltd and changed its name to Hyphens Pharma International Limited in May 2018. Hyphens Pharma International Limited was founded in 1998 and is headquartered in Singapore.
Compare HYPH to Peers and Sector
Metrics to compare | HYPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHYPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | 17.2x | 20.2x | −0.5x | |
PEG Ratio | −0.40 | 0.45 | 0.00 | |
Price/Book | 1.4x | 2.8x | 2.6x | |
Price / LTM Sales | 0.6x | 3.9x | 3.2x | |
Upside (Analyst Target) | 27.7% | 27.3% | 50.1% | |
Fair Value Upside | Unlock | 18.5% | 8.6% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 0.415
(+29.69% Upside)
Earnings
Latest Release
Feb 24, 2026
EPS / Forecast
0.01 / --
Revenue / Forecast
87.82M / --
FAQ
What Is the Hyphens Pharma (HYPH) Stock Price Today?
The Hyphens Pharma stock price today is 0,320 SGD.
What Stock Exchange Does Hyphens Pharma Trade On?
Hyphens Pharma is listed and trades on the Singapore Stock Exchange.
What Is the Stock Symbol for Hyphens Pharma?
The stock symbol for Hyphens Pharma is "HYPH."
Does Hyphens Pharma Pay Dividends? What’s The Current Dividend Yield?
The Hyphens Pharma dividend yield is 4.62%.
What Is the Hyphens Pharma Market Cap?
As of today, Hyphens Pharma market cap is 98,840M SGD.
What Is Hyphens Pharma's Earnings Per Share (TTM)?
The Hyphens Pharma EPS (TTM) is 0,019.
When Is the Next Hyphens Pharma Earnings Date?
Hyphens Pharma will release its next earnings report on May 18, 2026.
From a Technical Analysis Perspective, Is HYPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hyphens Pharma Stock Split?
Hyphens Pharma has split 0 times.
How Many Employees Does Hyphens Pharma Have?
Hyphens Pharma has 465 employees.
What is the current trading status of Hyphens Pharma (HYPH)?
As of Mar 04, 2026, Hyphens Pharma (HYPH) is trading at a price of 0,320 SGD, with a previous close of 0,325 SGD. The stock has fluctuated within a day range of 0,320 SGD to 0,325 SGD, while its 52-week range spans from 0,260 SGD to 0,395 SGD.
What Is Hyphens Pharma (HYPH) Price Target According to Analysts?
The average 12-month price target for Hyphens Pharma is 0,415 SGD, with a high estimate of 0.43 SGD and a low estimate of 0.4 SGD. 2 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +29,69% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.